Loading...
Fibroblast Growth Factor 23 and Acute Kidney Injury
Fibroblast growth factor 23 (FGF23) which is produced in bone, participates in the maintenance of phosphate metabolism and can serve as a biomarker for cardiovascular adverse outcomes in patients with chronic kidney and end-stage renal disease. Circulating FGF23 rapidly increases after acute kidney...
Na minha lista:
| Udgivet i: | Pediatr Nephrol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4458234/ https://ncbi.nlm.nih.gov/pubmed/25480729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-014-3006-1 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|